Literature DB >> 19008355

Dynamic NMR effects in breast cancer dynamic-contrast-enhanced MRI.

Xin Li1, Wei Huang, Elizabeth A Morris, Luminita A Tudorica, Venkatraman E Seshan, William D Rooney, Ian Tagge, Ya Wang, Jingang Xu, Charles S Springer.   

Abstract

The passage of a vascular-injected paramagnetic contrast reagent (CR) bolus through a region-of-interest affects tissue (1)H(2)O relaxation and thus MR image intensity. For longitudinal relaxation [R(1) identical with (T(1))(-1)], the CR must have transient molecular interactions with water. Because the CR and water molecules are never uniformly distributed in the histological-scale tissue compartments, the kinetics of equilibrium water compartmental interchange are competitive. In particular, the condition of the equilibrium trans cytolemmal water exchange NMR system sorties through different domains as the interstitial CR concentration, [CR(o)], waxes and wanes. Before CR, the system is in the fast-exchange-limit (FXL). Very soon after CR(o) arrival, it enters the fast-exchange-regime (FXR). Near maximal [CR(o)], the system could enter even the slow-exchange-regime (SXR). These conditions are defined herein, and a comprehensive description of how they affect quantitative pharmacokinetic analyses is presented. Data are analyzed from a population of 22 patients initially screened suspicious for breast cancer. After participating in our study, the subjects underwent biopsy/pathology procedures and only 7 (32%) were found to have malignancies. The transient departure from FXL to FXR (and apparently not SXR) is significant in only the malignant tumors, presumably because of angiogenic capillary leakiness. Thus, if accepted, this analysis would have prevented the 68% of the biopsies that proved benign.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19008355      PMCID: PMC2582941          DOI: 10.1073/pnas.0804224105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Determination of the MRI contrast agent concentration time course in vivo following bolus injection: effect of equilibrium transcytolemmal water exchange.

Authors:  C S Landis; X Li; F W Telang; J A Coderre; P L Micca; W D Rooney; L L Latour; G Vétek; I Pályka; C S Springer
Journal:  Magn Reson Med       Date:  2000-10       Impact factor: 4.668

2.  Equilibrium water exchange between the intra- and extracellular spaces of mammalian brain.

Authors:  James D Quirk; G Larry Bretthorst; Timothy Q Duong; Avi Z Snyder; Charles S Springer; Joseph J H Ackerman; Jeffrey J Neil
Journal:  Magn Reson Med       Date:  2003-09       Impact factor: 4.668

Review 3.  Antiangiogenic agents in breast cancer.

Authors:  John T Salter; Kathy D Miller
Journal:  Cancer Invest       Date:  2007-10       Impact factor: 2.176

4.  Shutter-speed analysis of contrast reagent bolus-tracking data: Preliminary observations in benign and malignant breast disease.

Authors:  Xin Li; Wei Huang; Thomas E Yankeelov; Alina Tudorica; William D Rooney; Charles S Springer
Journal:  Magn Reson Med       Date:  2005-03       Impact factor: 4.668

5.  A unified magnetic resonance imaging pharmacokinetic theory: intravascular and extracellular contrast reagents.

Authors:  Xin Li; William D Rooney; Charles S Springer
Journal:  Magn Reson Med       Date:  2005-12       Impact factor: 4.668

6.  The evaluation of esophageal adenocarcinoma using dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Eugene Y Chang; Xin Li; Michael Jerosch-Herold; Ryan A Priest; C Kristian Enestvedt; Jingang Xu; Charles S Springer; Blair A Jobe
Journal:  J Gastrointest Surg       Date:  2007-09-01       Impact factor: 3.452

7.  Water exchange and inflow affect the accuracy of T1-GRE blood volume measurements: implications for the evaluation of tumor angiogenesis.

Authors:  Y R Kim; K J Rebro; K M Schmainda
Journal:  Magn Reson Med       Date:  2002-06       Impact factor: 4.668

8.  First-pass dynamic contrast-enhanced MRI with extravasating contrast reagent: evidence for human myocardial capillary recruitment in adenosine-induced hyperemia.

Authors:  Xin Li; Charles S Springer; Michael Jerosch-Herold
Journal:  NMR Biomed       Date:  2009-02       Impact factor: 4.044

9.  The magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivo.

Authors:  Wei Huang; Xin Li; Elizabeth A Morris; Luminita A Tudorica; Venkatraman E Seshan; William D Rooney; Ian Tagge; Ya Wang; Jingang Xu; Charles S Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-12       Impact factor: 11.205

Review 10.  Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Authors:  P S Tofts; G Brix; D L Buckley; J L Evelhoch; E Henderson; M V Knopp; H B Larsson; T Y Lee; N A Mayr; G J Parker; R E Port; J Taylor; R M Weisskoff
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

View more
  43 in total

1.  Modeling of Look-Locker estimates of the magnetic resonance imaging estimate of longitudinal relaxation rate in tissue after contrast administration.

Authors:  Ramesh Paudyal; Hassan Bagher-Ebadian; Tavarekere N Nagaraja; Joseph D Fenstermacher; James R Ewing
Journal:  Magn Reson Med       Date:  2011-05-31       Impact factor: 4.668

2.  Discrimination of intra- and extracellular 23Na+ signals in yeast cell suspensions using longitudinal magnetic resonance relaxography.

Authors:  Yajie Zhang; Marie Poirer-Quinot; Charles S Springer; James A Balschi
Journal:  J Magn Reson       Date:  2010-04-01       Impact factor: 2.229

3.  A feasible high spatiotemporal resolution breast DCE-MRI protocol for clinical settings.

Authors:  Luminita A Tudorica; Karen Y Oh; Nicole Roy; Mark D Kettler; Yiyi Chen; Stephanie L Hemmingson; Aneela Afzal; John W Grinstead; Gerhard Laub; Xin Li; Wei Huang
Journal:  Magn Reson Imaging       Date:  2012-07-06       Impact factor: 2.546

4.  Observation of Reduced Homeostatic Metabolic Activity and/or Coupling in White Matter Aging.

Authors:  Valerie C Anderson; Ian J Tagge; Xin Li; Joseph F Quinn; Jeffrey A Kaye; Dennis N Bourdette; Rebecca I Spain; Louis P Riccelli; Manoj K Sammi; Charles S Springer; William D Rooney
Journal:  J Neuroimaging       Date:  2020-06-17       Impact factor: 2.486

5.  Intravoxel incoherent motion imaging of tumor microenvironment in locally advanced breast cancer.

Authors:  E E Sigmund; G Y Cho; S Kim; M Finn; M Moccaldi; J H Jensen; D K Sodickson; J D Goldberg; S Formenti; L Moy
Journal:  Magn Reson Med       Date:  2011-02-01       Impact factor: 4.668

6.  Analysis of pharmacokinetics of Gd-DTPA for dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Saeid Taheri; N Jon Shah; Gary A Rosenberg
Journal:  Magn Reson Imaging       Date:  2016-04-22       Impact factor: 2.546

7.  Dynamic-contrast-enhanced-MRI with extravasating contrast reagent: rat cerebral glioma blood volume determination.

Authors:  Xin Li; William D Rooney; Csanád G Várallyay; Seymur Gahramanov; Leslie L Muldoon; James A Goodman; Ian J Tagge; Audrey H Selzer; Martin M Pike; Edward A Neuwelt; Charles S Springer
Journal:  J Magn Reson       Date:  2010-07-31       Impact factor: 2.229

8.  Active trans-plasma membrane water cycling in yeast is revealed by NMR.

Authors:  Yajie Zhang; Marie Poirier-Quinot; Charles S Springer; James A Balschi
Journal:  Biophys J       Date:  2011-12-07       Impact factor: 4.033

9.  Markers of cochlear inflammation using MRI.

Authors:  Johann Le Floc'h; Winston Tan; Ravindra S Telang; Srdjan M Vlajkovic; Alfred Nuttall; William D Rooney; Beau Pontré; Peter R Thorne
Journal:  J Magn Reson Imaging       Date:  2013-04-15       Impact factor: 4.813

10.  Natural D-glucose as a biodegradable MRI contrast agent for detecting cancer.

Authors:  Kannie W Y Chan; Michael T McMahon; Yoshinori Kato; Guanshu Liu; Jeff W M Bulte; Zaver M Bhujwalla; Dmitri Artemov; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2012-10-16       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.